Research Article

Immunohistochemical Expression of Dual-Specificity Protein Phosphatase 4 in Patients with Colorectal Adenocarcinoma

Table 2

Correlation between DUSP4 expression and clinicopathological factors in colorectal adenocarcinomas ( = 439).

FactorsDUSP4 expression
Negative (%)
( = 273)
Positive (%)
( = 166)
value

Age (years)
 Mean ± SD43956.46 ± 13.3059.51 ± 11.330.0170.114
Gender
 Male239138 (57.7)101 (42.3)0.036−0.100
 Female200135 (67.5)65 (32.5)
Tumor location
 Colon227137 (60.4)90 (39.6)0.412−0.039
 Rectum212136 (64.2)76 (35.8)
Tumor size
 Mean ± SD4395.45 ± 1.926.05 ± 2.240.0140.117
Tumor type
 Nonmucinous418255 (61.0)163 (39.0)0.023−0.109
 Mucinous2118 (85.7)3 (14.3)
T category
 Tis, T1, T24635 (76.1)11 (23.9)0.0400.098
 T3, T4393238 (60.6)155 (39.4)
N category
 N0192123 (64.1)69 (35.9)0.6180.025
 N111468 (59.6)46 (40.4)
 N213382 (61.7)51 (38.3)
AJCC stage
 0, I, II191122 (63.9)69 (36.1)0.5220.031
 III, IV248151 (60.9)97 (39.1)
Dukes stage
 A, B187118 (63.1)69 (36.9)0.7330.016
 C, D252155 (61.5)97 (38.5)
Differentiation
 Well/Moderately347220 (63.4)127 (36.6)0.3080.049
 Poorly9253 (57.6)39 (42.4)
Lymphatic invasion
 Absent186120 (64.5)66 (35.5)0.3880.041
 Present253153 (60.5)100 (39.5)
Vascular invasion
 Absent429266 (62.0)163 (38.0)0.606−0.025
 Present107 (70.0)3 (30.0)

Mann-Whitney test; Chi-square test for independence; Chi-square test for linear trend.
DUSP4: dual specificity protein phosphatase 4; SD: standard deviation; AJCC: American Joint Committee on Cancer; : Spearman’s rank correlation coefficient.